Certolizumab pegol—what role does this new TNF inhibitor have in the treatment of RA?-Reference-Cited by-同舟云学术

Certolizumab pegol—what role does this new TNF inhibitor have in the treatment of RA?

Published:2009-02-03 Issue:3 Volume:5 Page:134-135
ISSN:1759-4790
Container-title:Nature Reviews Rheumatology
language:en
Short-container-title:Nat Rev Rheumatol

Author:

Furst Daniel E

Publisher

Springer Science and Business Media LLC

Subject

Rheumatology

Link

http://www.nature.com/articles/ncprheum1004.pdf

Reference5 articles.

1. Furst DE et al. (2008) Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008. Ann Rheum Dis 67 (Suppl 3): iii2–iii25

2. Nesbitt A et al. (2007) Mechanism of action of certolizumab pegol (CDP870): in vitro comparison with other anti-tumor necrosis factor alpha agents. Inflamm Bowel Dis 13: 1323–1332

3. Smolen JS et al. (2008) Efficacy and Safety of Certolizumab Pegol Plus Methotrexate in Active Rheumatoid Arthritis: The RAPID 2 Study. Ann Rheum Dis. [10.1136/ard.2008.101659]

4. Keystone E et al. (2008) Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis Rheum 58: 3319–3329

5. Fleischmann R et al. (2008) Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study. Ann Rheum Dis. [10.1136/ard.2008.099291]

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biologika und nicht infektiöse pulmonale Nebenwirkungen;Aktuelle Rheumatologie;2014-06-17

2. Non-infectious pulmonary complications of newer biological agents for rheumatic diseases--a systematic literature review;Rheumatology;2011-10-22

3. Certolizumab Pegol: A TNF-α Antagonist for the Treatment of Moderate-to-Severe Crohn's Disease;Annals of Pharmacotherapy;2010-01-05

4. The Discovery of Novel Experimental Therapies for Inflammatory Arthritis;Mediators of Inflammation;2009